Nephrotic syndrome in adults: diagnosis and management
- PMID: 19904897
Nephrotic syndrome in adults: diagnosis and management
Abstract
Nephrotic syndrome may be caused by primary (idiopathic) renal disease or by a variety of secondary causes. Patients present with marked edema, proteinuria, hypoalbuminemia, and often hyperlipidemia. In adults, diabetes mellitus is the most common secondary cause, and focal segmental glomerulosclerosis and membranous nephropathy are the most common primary causes. Venous thromboembolism is a possible complication; acute renal failure and serious bacterial infection are also possible, but much less common. There are no established guidelines on the diagnostic workup or management of nephrotic syndrome. Imaging studies are generally not needed, and blood tests should be used selectively to diagnose specific disorders rather than for a broad or unguided workup. Renal biopsy may be useful in some cases to confirm an underlying disease or to identify idiopathic disease that is more likely to respond to corticosteroids. Treatment of most patients should include fluid and sodium restriction, oral or intravenous diuretics, and angiotensin-converting enzyme inhibitors. Some adults with nephrotic syndrome may benefit from corticosteroid treatment, although research data are limited. Intravenous albumin, prophylactic antibiotics, and prophylactic anticoagulation are not currently recommended.
Summary for patients in
-
Patient information. Nephrotic syndrome.Am Fam Physician. 2009 Nov 15;80(10):1136. Am Fam Physician. 2009. PMID: 19908404 No abstract available.
Similar articles
-
Pharmacologic management of adult idiopathic nephrotic syndrome.Clin Pharm. 1993 Jun;12(6):429-39. Clin Pharm. 1993. PMID: 8403814 Review.
-
Diagnosis and Management of Nephrotic Syndrome in Adults.Am Fam Physician. 2016 Mar 15;93(6):479-85. Am Fam Physician. 2016. PMID: 26977832 Review.
-
[Refractory nephrotic syndrome].Nihon Rinsho. 2004 Oct;62(10):1794-9. Nihon Rinsho. 2004. PMID: 15500120 Review. Japanese.
-
Idiopathic focal segmental glomerulosclerosis.Semin Nephrol. 2003 Mar;23(2):183-93. doi: 10.1053/snep.2003.50016. Semin Nephrol. 2003. PMID: 12704578 Review.
-
[Edema and the nephrotic syndrome].Ther Umsch. 2004 Nov;61(11):655-60. doi: 10.1024/0040-5930.61.11.655. Ther Umsch. 2004. PMID: 15605457 German.
Cited by
-
A Novel CLCN5 Splice Site Mutation in a Boy with Incomplete Phenotype of Dent Disease.J Pediatr Genet. 2019 Dec;8(4):235-239. doi: 10.1055/s-0039-1692172. Epub 2019 Jun 4. J Pediatr Genet. 2019. PMID: 31687264 Free PMC article.
-
Management of nephrotoxicity of chemotherapy and targeted agents: 2020.Am J Cancer Res. 2020 Dec 1;10(12):4151-4164. eCollection 2020. Am J Cancer Res. 2020. PMID: 33414992 Free PMC article. Review.
-
Soy-based renoprotection.World J Nephrol. 2016 May 6;5(3):233-57. doi: 10.5527/wjn.v5.i3.233. World J Nephrol. 2016. PMID: 27152261 Free PMC article. Review.
-
Experimental models for preclinical research in kidney disease.Zool Res. 2024 Sep 18;45(5):1161-1174. doi: 10.24272/j.issn.2095-8137.2024.072. Zool Res. 2024. PMID: 39257378 Free PMC article. Review.
-
Development and validation of nomogram prediction model for severe kidney disease in children with Henoch-Schönlein purpura: A prospective analysis of two independent cohorts-forecast severe kidney disease outcome in 2,480 hospitalized Henoch-Schönlein purpura children.Front Immunol. 2022 Oct 12;13:999491. doi: 10.3389/fimmu.2022.999491. eCollection 2022. Front Immunol. 2022. PMID: 36311786 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources